IO Biotech (IOBT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist

0.821
-0.049-5.68%

Close Nov 20 16:00 ET

0.810
-0.011-1.29%

Pre 08:47 ET

54.06MMarket Cap-636P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

TD Cowen Maintains IO Biotech(IOBT.US) With Buy Rating
Moomoo NewsNov 12 20:31 ET · Ratings
Promising Clinical Progress and Financial Stability Drive Buy Rating for IO Biotech
TipRanksNov 12 20:05 ET · Ratings
IO Biotech | 10-Q: Q3 2024 Earnings Report
SECNov 12 16:37 ET · Announcements
Express News | HC Wainwright & Co. Reiterates Buy on IO Biotech, Maintains $12 Price Target
BenzingaNov 12 11:21 ET
IO Biotech Analyst Ratings
BenzingaNov 12 11:20 ET · Ratings
Positive Outlook for IO Biotech Amid Promising Clinical Developments in Melanoma and Head & Neck Cancer Trials
TipRanksNov 12 10:56 ET

Comments

Jaguar8

Nov 7 09:02

NEWS

$IO Biotech (IOBT.US)$
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
IO Biotech announced promising Phase 2 results for its cancer vaccine IO102-IO103 combined with KEYTRUDA® in first-line metastatic lung cancer treatment. The study showed a 55% unconfirmed/48% confirmed overall response rate and 8...